
Advancing oral immunotherapy for food allergies
Professor Mimi Tang discusses multi-year follow up from the PPOIT-003 Phase IIb programme and how these data help clarify distinct post-treatment clinical states, including remission and desensitisation, and their implications for durability, adherence, and real-world patient experience once structured therapy is complete. Recent multi-year data from the PPOIT-003 and PPOIT-003LT… Read More







